![Tim Collard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 572 574 $ al 30/06/2026
Tim Collard currently works as the Chief Executive Officer at Pacific GeneTech Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Recce Pharmaceuticals Ltd.
 Recce Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Creates and manufactures antibiotics 0,71 % | 28/02/2025 | 2.040.680 ( 0,71 % ) | 572 574 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Pacific GeneTech Ltd.
 Pacific GeneTech Ltd. BiotechnologyHealth Technology Develops and commercializes vaccines for the livestock industry | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 1 |
|---|---|
Pacific GeneTech Ltd.
Pacific GeneTech Ltd. BiotechnologyHealth Technology Develops and commercializes vaccines for the livestock industry | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
